| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/07/2009 | WO2009056551A1 Furo[3,2-d]pyrimidine derivatives |
| 05/07/2009 | WO2009037001A3 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 05/07/2009 | WO2009021957A3 Tricyclic heterocyclic compounds as gaba a modulators |
| 05/07/2009 | US20090118356 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 05/07/2009 | US20090118319 Fused and Spirocycle Compounds and the Use Thereof |
| 05/07/2009 | US20090118271 Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118232 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | CA2703978A1 Thiazole derivatives as protein kinase inhibitors |
| 05/06/2009 | EP2054384A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 05/06/2009 | EP1242082B1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/06/2009 | CN101423519A Tetrandrine organic acid salt as well as preparation method and application |
| 05/06/2009 | CN100484940C Water-soluble camptothecine derivative and its preparation process and application thereof |
| 05/06/2009 | CN100484939C Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/05/2009 | US7528167 Inhibitors of papilloma virus |
| 05/05/2009 | US7528165 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/05/2009 | US7528148 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/05/2009 | US7528147 e.g. 2 {5,6-dimethoxy-1-[2-(4-methylpiperazin- 1 -yl)ethyl]-1H-indol-3 -yl}-1H-pyrrolo[2,3- b]pyridine; Insulin Growth Factor-1 (somatomedin) antagonist; antiproliferative, antitumor agent; solid tumor; prostate, lung and breast cancer |
| 04/30/2009 | WO2009055633A1 Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 04/30/2009 | WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 04/30/2009 | WO2009054864A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | WO2009015037A3 5-pyridinone substituted indazoles |
| 04/30/2009 | WO2008115890A3 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2007050810A3 Fluorogenic probes for reactive oxygen species |
| 04/30/2009 | US20090111869 Benzoquinone ansamycins |
| 04/30/2009 | US20090111845 Treating a cancer or malignant tumor using the crystalline camptothecin ester hydrates; nontoxic |
| 04/30/2009 | US20090111842 Spirocyclic cyclohexane compounds with analgesic activity |
| 04/30/2009 | US20090111699 Weakly Basic Hindered Amines Having Carbonate Skeletons, Synthetic Resin Compositions, And Coating Compositions |
| 04/30/2009 | US20090111151 Production of Polyketides |
| 04/30/2009 | DE102007047737A1 Piperidin- und Piperazinderivate Piperidine and piperazine derivatives |
| 04/30/2009 | CA2704052A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 04/30/2009 | CA2703054A1 Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 04/29/2009 | EP2051981A1 1h-furo[3,2-c] pyrazole compounds useful as kinase inhibitors |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections |
| 04/29/2009 | CN101421273A Spiro-imidazo compounds |
| 04/29/2009 | CN101421268A Pyrazoloquinolones as potent PARP inhibitors |
| 04/29/2009 | CN100482667C Method for preparing 5-bromine-6-fluoro-8-methyl-1-ethyl-1,3,4,9- tetrahydropyrane[3,4-e] indole-1-ethyl acetate |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524956 Hemisynthetic method and new compounds |
| 04/28/2009 | US7524862 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/28/2009 | US7524860 Antibacterial agents |
| 04/28/2009 | US7524856 Tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2009 | US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 04/23/2009 | WO2009049476A1 Process for the manufacture of (+)-biotin |
| 04/23/2009 | WO2005037992A3 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 04/23/2009 | US20090105294 Biosynthetic Gene Cluster for the Production of a Complex Polyketide |
| 04/23/2009 | US20090105292 Glucocorticoid Receptor Modulator Compounds and Methods |
| 04/23/2009 | US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105072 2-(Pyridin-2-Yl)-Pyrimidines for Use as Fungicides |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2700905A1 C7-substituted camptothecin analogs |
| 04/22/2009 | EP2050752A1 Isoquinuclidine derivative and method for producing 1-cyclohexene-1-carboxylic acid derivative by using the same |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050452A1 indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents |
| 04/22/2009 | EP2049545A2 Methods of making esters of camptothecins |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049482A1 Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 04/22/2009 | EP2003135A9 Process for producing optically active chromene oxide compound |
| 04/22/2009 | EP1795527B1 Carbamoyl-substituted spiro derivative |
| 04/22/2009 | EP1539761B1 6,7-dihydro-5h-pyrazolo¬1,2-a pyrazol-1-ones which control inflammatory cytokines |
| 04/22/2009 | EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 04/22/2009 | CN100480389C Production of polyketides |
| 04/22/2009 | CN100480241C Kukoline C ring modified derivative and synthesis method thereof |
| 04/21/2009 | US7521475 Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof |
| 04/21/2009 | US7521458 Spiropiperidylrifamycins for the treatment of mycobacterial infections |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009049233A1 Method for treating and/or preventing drug seeking behavior |
| 04/16/2009 | WO2009047558A1 Benzothiazoles as ghrelin receptor modulators |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2009046624A1 Preparation methods of (4s,5r)-semi-esters |
| 04/16/2009 | WO2008124571A3 Anti-viral compounds, compositions and methods |
| 04/16/2009 | US20090099227 G-Protein Coupled Receptor Agonists |
| 04/16/2009 | US20090099222 Modulators of muscarinic receptors |
| 04/16/2009 | US20090098636 Fungal cell wall synthesis gene |
| 04/16/2009 | CA2702181A1 Benzothiazoles as ghrelin receptor modulators |
| 04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
| 04/15/2009 | EP2046800A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 04/15/2009 | EP2046799A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
| 04/15/2009 | EP2046798A1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 04/15/2009 | EP2046797A1 Furo [3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 04/15/2009 | EP2046796A1 Tetrahydrofuro [3, 2 -b]pyrr0l-3-ones as cathepsin k inhibitors |
| 04/15/2009 | EP2046795A1 Furo[3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 04/15/2009 | EP1861092A4 Potassium channel opener having benzofuroindole skeleton |
| 04/15/2009 | EP1432680B1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 04/15/2009 | CN101410401A Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410388A Compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101407520A Novel medical uses of aporphine alkaloid and derivative thereof |
| 04/15/2009 | CN101407514A Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| 04/15/2009 | CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/14/2009 | US7517982 Naphthols useful for preparing indeno-fused photochromic naphthopyrans |